Acceptability of fluzone intradermal vaccine to patients and vaccine administrators

Journal of the American Osteopathic Association

Volumn 113, Issue 2, 2013, Pages 134-143

  Foy, James E ^a   Hendriksz, Tami ^a   Malouf, Philip ^a   Tobin, Allison ^a  

^a Touro University California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; INTRADERMAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MICROINJECTION; MIDDLE AGED; PATIENT ATTITUDE; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES; VACCINATION; YOUNG ADULT; INFLUENZA, HUMAN; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CALIFORNIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; MALE; MICROINJECTIONS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 84874206288     PISSN: 00986151     EISSN: 19451997     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59(33):1057-1062.
2. Tosh PK, Jacobson RM, Poland GA. Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc. 2010;85(3):257-273.
3. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2012;61(32);613-618.
4. US Department of Health and Human Services. Immunization and infectious diseases. Healthy People 2020 website. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=23. Accessed Jan 13, 2012.
5. Setse RW, Euler GL, Gonzalez-Feliciano AG, et al. Influenza vaccination coverage-United States, 2000-2010. MMWR Suppl. 2011;60(1):38-41.
6. US Department of Health and Human Services. Influenza vaccination of healthcare personnel. In: National Action Plan to Prevent Healthcare-Associated Infections: Roadmap to Elimination. http://www.hhs.gov/ash/initiatives/hai/hcp_flu.pdf. Accessed January 20, 2013.
7. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7)(suppl 2):S28-S35. doi:10.1016/j.amjmed.2008.05.005.
8. Atmar RL, Patel SM, Keitel WA. Intanza: a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines. 2010;9(12):1399-1409.
9. Fluzone [package insert]. Swiftwater, PA: Sanofi Pasteur Inc; 2011. http://www.fda.gov/downloads/biologicsbloodvaccines/.../ucm195479.pdf. Accessed December 15, 2012.
10. Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther. 2011;28(8):640-649. doi:10.1007/s12325-011-0042-0.